References
Beta-Methylphenethylamine (BMPEA)
21078
Pawar RS, Grundel E, Fardin-Kia AR, Rader JI. Determination of selected biogenic amines in Acacia rigidula plant materials and dietary supplements using LC-MS/MS methods. J Pharm Biomed Anal. 2014 Jan;88:457-66. doi: 10.1016/j.jpba.2013.09.012. Epub 2013 Oct 5. View abstract.
21079
Venhuis B, Keizers P, van Riel A, de Kaste D. A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Test Anal. 2014 Jun;6(6):578-81. doi: 10.1002/dta.1664. Epub 2014 May 6. View abstract.
29823
Cohen PA, Bloszies C, Yee C, Gerona R. An amphetamine isomer whose efficacy and safety in humans has never been studied, ß-methylphenylethylamine (BMPEA), is found in multiple dietary supplements. Drug Test Anal. 2015 Apr 7. View abstract.
89219
Cohen PA, Zeijlon R, Nardin R, Keizers PH, Venhuis B. Hemorrhagic Stroke Probably Caused by Exercise Combined With a Sports Supplement Containing ß-Methylphenyl-ethylamine (BMPEA): A Case Report. Ann Intern Med. 2015 Jun 16;162(12):879-80. doi: 10.7326/L15-5101. View abstract.
90001
BMPEA in Dietary Supplements. FDA Q & A on Dietary Supplements, April 23, 2015. Available at: http://www.fda.gov/Food/DietarySupplements/QADietarySupplements/ucm443790.htm.
91878
Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. View abstract.
92470
Mosnaim AD, Callaghan OH, Hudzik T, et al. Rat brain-uptake index for phenylethylamine and various monomethylated derivatives. Neurochem Res 2013;38:842-6. View abstract.
94317
Brown DH, Hansson R, Oosthuizen F, et al. ß-Methylphenylethylamines: common fragmentation pathways with amphetamines in electrospray ionization collision-induced dissociation. Drug Test Anal 2016;8:344-50. View abstract.
94385
Cholbinski P, Wicka M, Kowalczyk K, et al. Detection of ß-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS. Anal Bioanal Chem 2014;406:3681-8. View abstract.
94386
Pawar RS, Grundel E. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs). Drug Test Anal 2017;9:500-517. View abstract.
102059
Rickli A, Hoener MC, Liechti ME. Pharmacological profiles of compounds in preworkout supplements ("boosters"). Eur J Pharmacol 2019;859:172515. View abstract.
103275
Schindler CW, Thorndike EB, Rice KC, Partilla JS, Baumann MH. The supplement adulterant ß-methylphenethylamine increases blood pressure by acting at peripheral norepinephrine transporters. J Pharmacol Exp Ther. 2019;369(3):328-36. View abstract.
107387
Duiven E, van Loon LJC, Spruijt L, Koert W, de Hon OM. Undeclared doping substances are highly prevalent in commercial sports nutrition supplements. J Sports Sci Med. 2021 Mar 22;20(2):328-38. View abstract.
114931
McGriff SA, Chojnacki MR, Thorndike EB, Rice KC, Baumann MH, Schindler CW. Reinforcing effects of phenethylamine analogs found in dietary supplements. Psychopharmacology (Berl) 2022;239(11):3723-3730. View abstract.